透明质酸
骨关节炎
化学
生物医学工程
药理学
材料科学
脂质体
溶解
纳米技术
医学
毒品携带者
生物相容性
药品
纳米医学
聚合物
尼奥体
生物相容性材料
靶向给药
作者
Junfeng Ban,Yichao Li,Yanhua Guo,Huashen He,Chuangzan Yang,Peining Li,Jiawei Liang,Shirui Li,Xueyuan Luo,Yu Li,Yi Xie,Xiangmei Liu,Xiaofang Li
摘要
Background: Rapid local drug clearance and poor sustained retention pose challenges to the treatment of osteoarthritis. Therefore, a local delivery system that prolongs intra-articular drug retention and achieves efficient targeted delivery holds significant clinical promise. Methods: Hyaluronic acid-modified celecoxib nanostructured lipid carriers (HA-Cxb-NLCs) were prepared and encapsulated in dissolving microneedles to form a composite delivery system (HA-Cxb-NLCs-DMNs). The system was characterised in terms of its physicochemical properties, in vitro drug release profiles, transdermal permeation behaviour, cellular compatibility, and uptake mechanisms. Subsequently, a sodium iodoacetate-induced rat osteoarthritis model was used to evaluate the therapeutic efficacy in vivo. Results: HA-Cxb-NLCs-DMNs exhibit a uniform particle size (113.93 ± 1.66 nm) and a zeta potential of (− 39.16 ± 3.00 mV). In vitro release persisted for 72 hours, with a cumulative permeation of 62.74 ± 1.40 μg·cm − 2 and a skin retention of 3.20 ± 0.62 μg·cm − 2 . HA modification enhances cellular uptake of the nanocarriers via the CD44 receptor. Animal studies demonstrated that it reduces joint swelling, improves cartilage damage, and inhibits MMP-13 expression. Conclusion: This study presents a promising microneedle-nanoparticle synergistic delivery strategy for the local targeted therapy of osteoarthritis. Keywords: dissolving microneedles, hyaluronic acid-modified celecoxib nanolipid carrier, osteoarthritis, transdermal administration
科研通智能强力驱动
Strongly Powered by AbleSci AI